Role of dendritic cells in the immunopathogenesis and therapy of liver diseases

Japanese Journal of Clinical Immunology

Volumn 27, Issue 2, 2004, Pages 64-76

  Onji, Morikazu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

antigen presentation; Dendritic cells; hepatitis virus; liver diseases; therapy

Indexed keywords

ANIMAL; CYTOLOGY; DENDRITIC CELL; HUMAN; IMMUNOLOGY; LIVER; LIVER DISEASE; REVIEW;

ANIMALS; DENDRITIC CELLS; HUMANS; LIVER; LIVER DISEASES;

EID: 3042633513     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.27.64     Document Type: Article

References (67)

1. Banchereau J, Briere F, Caux C, et al.: Immunobiology of dendritic cells. Annu Rev Immunol 18: 767–811, 2000.
2. Lotze MT and Thomson AW: Dendritic Cells. Academic Press, San Diego, 2001.
3. Jego G, Palucka AK, Blanck JP, et al.: Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19: 225–234, 2003.
4. Onji M: Dendritic Cells in Clinics, Springer–Verlag, Tokyo, 2003.
5. O’Farrelly C, Crispe IN: Prometheus through the looking glass: reflections on the hepatic immune system. Immunol Today 20: 394–398, 1999.
6. Mehal WZ, Azzaroli F, Crispe IN: Immunology of the healthy liver: old questions and new insights. Gastroenterology 120: 250–260, 2001.
7. Kita H, Mackay IR, Van De Water J et al.: The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology 120: 1485–1501, 2001.
8. Jaeschke H: Cellular adhesion molecules: regulation and functional significance in the pathogenesis of liver diseases. Am J Physiol 273: G602–611, 1997.
9. Tsuneyama K, Harada K, Yasoshima M, et al.: Monocyte chemotactic protein-1,-2 and –3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis. J Pathol 193: 102–109, 2001.
10. Takeda K, Hayakawa Y, Van Kaer L, et al.: Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 97: 5498–5503, 2000.
11. Tseng CT, Miskovsky E, Houghton M et al.: Characterization of liver T–cell receptor γδ+T cells obtained from individuals chronically infected with hepatitis C virus (HCV): Evidence for these T cells playing a role in the liver pathology associated with HCV infections. Hepatology 33: 1312–1320, 2001.
12. Matsuno K, Ezaki T: Dendritic cell dynamics in the liver and hepatic lymph. Int Rev Cytol 197: 83–136, 2000.
13. Woo J, Lu L, Rao AS, et al.: Isolation, phenotype, and allostimulatory activity of mouse liver dendiritic cells. Transplantation 58:484-491, 1994.
14. Knolle PA, Schmitt E, Jin S, et al.: Induction of cytokine production in naive CD4 + T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Thl cells. Gastroenterology 116: 1428–1440, 1999.
15. Abe M, Akbar SMF, Horiike N, et al.: Induction of cytokine production and proliferation of memory lymphocytes by murine liver dendritic cell progenitors: role of these progenitors as immunogenic resident antigen-presenting cells in the liver. J Hepatol 34: 61–67, 2001.
16. Crispe IN: Hepatic T cells and liver tolerance. Nat Rev Immunol, 3: 51–62, 2003.
17. Akbar SMF, Onji M, Inaba K, Yamamura K-I, Ohta Y: Low responsiveness of hepatitis B virus-transgenic mice in antibody response to T-cell dependent antigen: defect in antigen-presenting activity of dendritic cells. Immunology 78: 468–475, 1993.
18. Akbar SMF, Inaba K, Onji M: Upregulation of MHC classs II antigen on dendritic cells from hepatitis B virus transgenic mice by interferon-gamma: abrogation of immune response defect to a T-cell-dependent antigen. Immunology 87: 519–527, 1996.
19. Kurose K, Akbar SNF, Yamamoto K, Onji M: Production of antibody to hepatitis B surface antigen (anti–HBs) by murine hepatitis B virus carriers: neonatal tolerance versus antigen presentation by dendritic cells. Immunology 92: 494–500, 1997.
20. Kumon I, Onji M, Nadano S, Kanaoka M, Ohta Y: Detection of hepatitis B surface antigen in lymphoid follicle in patients with chronic hepatitis type B. Gastroenterol Jpn 24: 738, 1989.
21. Kumon I: In situ characterization of mononuclear cell phenotype in intrahepatic lymphoid follicles in patients with chronic viral hepatitis. Gastroenterol Jpn 27: 638–645, 1992.
22. Abe M, Akbar SMF, Horiike N, Onji M: Induction of cytokine production and proliferation of memory lymphocytes progenitors as immunogenic resident antigen–presenting cells in the liver: J Hepatol 34: 67–71, 2001.
23. Tanimoto K, Akbar SMF, Michitaka K, Horiike N, Onji M: Antigen-presenting cells at the liver tissue in patients with chronic viral liver diseases: CD83–positive mature dendritic cells at the vicinity of focal and confluent necrosis: Hepatol Res 21: 117–125, 2001.
24. Arima S, Akbar SMF, Michitaka K, Horiike N, Nuriya H, Kohara M, Onji M: Impaired function of antigen-presenting dendritic cells in patients with chronic hepatitis B: localization of HBV DNA and HBV RNA in blood DC by in situ hybridization. Int J Mol Med 11: 169–174, 2003.
25. Wang FS, Xing LH, Liu MX, et al.: Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J Gastroenterol 7: 537–541, 2001.
26. Lohr HF, Pingel S, Bocher WO, et al.: Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B–restoration by exogenous interleukin-12. Clin Exp Immunol 130: 107–114, 2002.
27. Horiike N, Akbar SMF, Ninomiya T, Abe M, Michitaka K, Onji M: Activation and maturation of antigen-presenting dendritic cells during vaccine therapy in patients with chronic hepatitis due to hepatitis B virus: Hepatol Res 23: 38–47, 2002.
28. Akbar SMF, Horiike N, Onji M, et al.: Dendritic cells and chronic hepatitis virus carriers. Intervirology 44: 199–208, 2001.
29. Akbar SMF, Horiike N, Onji M: Prognostic importance of antigen-presenting dendritic cells during vaccine therapy in a murine hepatitis B virus carrier. Immunology 96: 98–108, 1999.
30. Akbar SMF, Kajino K, Tanimoto K, Kurose K, Masumoto T, Michitaka K, Horiike N, Onji M: Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice. J Hepatol 26: 131–137, 1997.
31. Akbar SMF, Abe M, Masumoto T, Horiike N, Onji M: Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells. J Hepatol 30: 755–764, 1999.
32. Oka Y, Akbar SMF, Horiike N, Joko K, Onji M: Mechanism and therapeutic potential of DNA–based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice: Immunology 103: 90–97, 2001.
33. Akbar SMF, Furukawa S, Horiike N, Michitaka K, Onji M. (submitted).
34. Furukawa S, Akbar SMF, Hasebe A, Horiike N, Onji M.: Induction and maintenance of anti–HBs in immunosuppressed murine hepatitis B virus carrier by a novel vaccination approach: implication during liver transplantation in hepatitis B virus infected subjects. J. Gastroenteral (in press).
35. Furukawa S, Akbar SMF, Hasebe A, Horiike N, Onji M. (submitted).
36. Akbar SMF, Furukawa S, Onji M, Murata Y, Niiya T, Kanno S, Murakami H, Horiike N.: Safety and efficacy of hepatitis B surface antigen-pulsed dendritic cells in human volunteers Hepatol Res (in press).
37. Hiasa Y, Horiike N, Akbar SMF, Saito I, Miyamura T, Matsuura Y, Onji M: Low stimulatory capacity of lymphoid dendritic cells expressing hepatitis C virus genes. Biochem Biophys Res Commun 249: 90–95, 1998.
38. Kanto T, Hayashi N, Takehara T, et al.: Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 162: 5584–5591, 1999.
39. Bain C, Fatmi A, Zoulim F, et al: Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120: 512–524, 2001.
40. Auffermann-Gretzinger S, Keeffe EB, Levy S: Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C infection. Blood 97: 3171–3176, 2001.
41. Sarobe P, Lasarte JJ, Casares N, et al.: Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and El proteins. J Virol 76: 5062–5070, 2002.
42. Jinushi M, Takehara T, Tatsumi T, et al.: Autocrine/paracrine IL-15 that is required for type I IFN–mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J Immunol 15: 5423–5429, 2003.
43. Jinushi M, Takehara T, Kanto T, et al.: Critical role of MHC class I–related chain A and B expression on IFN–alpha-stimualted dendritic cells in NK cell activation: impairement in chronic hepatitis C virus infection. J Immunol 170: 1249–1256, 2003.
44. Yamamoto K, Akbar SMF, Masumoto T, Onji M: Increased nitric oxide (NO) production by antigen-presenting dendritic cells is responsible for low allogeneic mixed leucocyte reaction (MLR) in primary biliary cirrhosis (PBC). Clin Exp Immunol 114: 94–101, 1998.
45. Longman RS, Talal AH, Jacobson IM, et al.: Presence of funotional dendritic cells in patients chronically infected with hepatitis C virus. Blood, 103: 1026–1029, 2004.
46. Rollier C, Drexhage JR, Verstrepen BE, et al.: Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment. Hepatology 38: 851–858, 2003.
47. Brady MT, MacDonald AJ, Rowan AG, et al.: Hepatitis C virus non-structural protein 4 suppresses Thl responses by stimulating IL-10 production from monocytes. Eur J Immunol 33: 3448–3457, 2003.
48. Tsubouchi E, Akbar SMF, Horiike N, et al.: Infection and dysfunction of circulatingblood dendritic cells and their subsets in chronic hepatitis C virus infection. J Gastroenterol (in press).
49. Tsubouchi E, Akbar SMF, Murakami H, Horiike N, Onji M. (submitted).
50. Sevilla N, Kunz S, Holz A, et al.: Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J Exp Med 192: 1249–1260, 2000.
51. Murakami H, Akbar SMF, Matsui H, Horiike N, Onji M. (submitted).
52. Matsuura Y, Tani H, Suzuki K, et al.: Characterization of pseudotype VSV possessing HCV envelope proteins. Virology 286:263-275, 2001.
53. Abe M, Akbar SMF, Horiike N, Onji M: Inability of liver dendritic cells from mouse with experimental hepatitis to process and present specific antigens: Hepatol Res 26: 61–67, 2003.
54. Abe M, Akbar SMF, Horiike N, Onji M: Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis. J Gastroenterol 38: 962–967, 2003.
55. Ninomiya T, Akbar SMF, Masumoto T, Horiike N, Onji M: Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma. J Hepatol 31: 323–331, 1999.
56. Kakumu S, Ito S, Ishikawa T, et al.: Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection. J Gastroenterol Hepatol 15: 431–436, 2000.
57. Chen S, Akbar SMF, Tanimoto K, Ninomiya T, Iuchi H, Michitaka K, Horiike N, Onji M: Absence of CD83–positive mature and Activated dendritic cells at cancer nodules from patients with hepatocelluar carcinoma: relevance to hepatocarcinogenesis. Cancer Lett 148: 49–57, 2000.
58. Homma S, Toda G, Gong J, et al.: Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice. J Gastroenterol 36: 764–771, 2001.
59. Ladhams A, Schmidt C, Sing G, et al.: Treament of non-resectable hepatocellular carcinoma with autologous tumor-pulsed dendritic cells. J Gastroetnerol Hepatol 17: 889–896, 2002.
60. Onji M, Akbar SMF, Horiike N: Dendritic cell-based immunotherapy for hepatocellular carcinoma: J Gastroenterol 36: 794–797, 2001.
61. Kumagi T, Akbar SMF, Horiike N, et al.: Increased survival and decreased tumor size due to intratumoral injection of ethanol followed by administration of immature dendritic cells. Int J Oncol 23: 949–955, 2003.
62. Shinomiya M, Masumoto T, Nadano S, Akbar SMF, Onji M: Lymphoid dendritic cells in the liver of patients with primary biliary cirrhosis and its mouse model. Hepatol Res 1: 84–94, 1998.
63. Tanimoto K, Akbar SMF, Michitaka K, Onji M: Immunohistochemical localization of antigen presenting cells in liver from patients with primary biliary cirrhosis: highly restricted distribution of CD83–positive activated dendritic cells. Pathol Res Pract 195: 157–162, 1999.
64. Akbar SMF, Yamamoto K, Miyakawa H, Ninomiya T, Abe M, Hiasa Y, Masumoto T, Horiike N, Onji M: Peripheral blood T–cell responses to pyruvate dehydrogenase complex in primary biliary cirrhosis: role of antigen-presenting dendritic cells: Eur J Clin Invest 31: 639–646, 2001.
65. Hiasa Y, Akbar SMF, Abe M, Michitaka K, Horiike N, Onji M: Dendritic cell subtypes in autoimmune liver diseases; decreased expression of HLA DR and CD 123 on type 2 dendritic cells: Hepatol Res 22: 241–249, 2002.
66. Huang YM, Yang JS, Xu LY, et al.: Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats. Clin Exp Immunol 122: 437–444, 2000.
67. Mahnke K, Knop J, Enk AH: Induction of tolerogenic DCs: ’you are what you eat’. Trends Immunol 24: 646–651, 2003.